This inventor holds 7 USPTO granted patents, plus 1 CIPO patent and 1 EPO patent. Top assignees: Korea Institute of Science and Technology, Ilab. Active years: 1997-2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1997-2023
Title: **Kye Jung Shin: Innovator in TNF-Related Therapeutics**
Introduction
Kye Jung Shin is an esteemed inventor based in Seoul, South Korea, known for his significant contributions to the field of medical science. With a total of seven patents to his name, Shin has dedicated his career to the development of innovative therapies aimed at treating TNF-related diseases, showcasing his commitment to advancing healthcare solutions.
Latest Patents
His latest patents focus on a composition for preventing or treating TNF-related diseases, which includes a novel 4-benzopyranone derivative as the active ingredient. This invention represents a groundbreaking approach that allows for oral administration of treatments, thereby avoiding injection-related side effects and immunological tolerance. The patented compositions effectively inhibit TNF activity by binding directly to TNF, allowing for enhanced dosage control and co-administration with conventional oral preparations. This innovative method underscores the potential for improved patient compliance and therapeutic outcomes in the treatment of TNF-related diseases.
Career Highlights
Kye Jung Shin has made a name for himself in notable institutions, including the Korea Institute of Science and Technology and Ilab. His work in these organizations emphasizes his role as a leading figure in research and development, focusing on the advancement of pharmaceutical compositions and methodologies that tackle challenging health issues.
Collaborations
Throughout his career, Shin has collaborated with esteemed colleagues such as Eun Joo Roh and Kyung Il Choi. These partnerships highlight the importance of teamwork in the research and development process, enabling the sharing of diverse ideas and expertise that propel innovations forward.
Conclusion
Kye Jung Shin's innovative patents and collaborative spirit reflect his dedication to addressing significant medical challenges. With his groundbreaking work on TNF-related diseases, he continues to contribute valuable solutions to the healthcare field, affirming his status as a prominent inventor in the realm of pharmaceutical sciences.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile